Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis
- PMID: 18444882
- DOI: 10.1086/588387
Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis
Abstract
Background: Post-kala-azar dermal leishmaniasis (PKDL), an established sequela of visceral leishmaniasis (VL), is proposed to facilitate anthroponotic transmission of VL, especially during interepidemic periods. Immunopathological mechanisms responsible for Indian PKDL are still poorly defined.
Methods: Our study attempted to characterize the immune profiles of patients with PKDL or VL relative to that of healthy control subjects by immunophenotyping, intracellular cytokine staining of peripheral blood mononuclear cells, and enzyme-linked immunosorbent assay for serum cytokines and immunoglobulin G (IgG) subclasses.
Results: Patients with PKDL had significantly raised percentages of peripheral CD3+CD8+ cells compared with control subjects, a difference that persisted after cure. Patients with PKDL showed an intact response to phytohemagglutinin, with the percentages of lymphocytes expressing interferon (IFN)-gamma, interleukin (IL)-2, IL-4, and IL-10 being comparable to those in control subjects. Patients with VL had decreased IFN-gamma and IL-2 expression, which was restored after cure, and increased IL-10 expression, which persisted after cure. In their response to Leishmania donovani antigen, patients with PKDL showed a 9.6-fold increase in the percentage of IL-10-expressing CD3+CD8+ lymphocytes compared with control subjects, and this percentage decreased with treatment. Patients with PKDL had raised levels of IgG3 and IgG1 (surrogate markers for IL-10), concomitant with increased serum levels of IL-10.
Conclusions: IL-10-producing CD3+CD8+ lymphocytes are important protagonists in the immunopathogenesis of Indian PKDL.
Similar articles
-
Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.Trans R Soc Trop Med Hyg. 2012 Nov;106(11):668-76. doi: 10.1016/j.trstmh.2012.07.005. Epub 2012 Aug 21. Trans R Soc Trop Med Hyg. 2012. PMID: 22920931
-
Post-kala-azar dermal leishmaniasis--an overview.Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x. Int J Dermatol. 2010. PMID: 21128917 Review.
-
Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.J Infect Dis. 2006 Oct 1;194(7):958-65. doi: 10.1086/506624. Epub 2006 Aug 23. J Infect Dis. 2006. PMID: 16960784
-
Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.J Invest Dermatol. 2010 Apr;130(4):1013-22. doi: 10.1038/jid.2009.393. Epub 2009 Dec 24. J Invest Dermatol. 2010. PMID: 20032994
-
The immunology of post-kala-azar dermal leishmaniasis (PKDL).Parasit Vectors. 2016 Aug 23;9(1):464. doi: 10.1186/s13071-016-1721-0. Parasit Vectors. 2016. PMID: 27553063 Free PMC article. Review.
Cited by
-
Is the IL-10 -819 polymorphism associated with visceral leishmaniasis?Inflammation. 2013 Dec;36(6):1513-8. doi: 10.1007/s10753-013-9693-0. Inflammation. 2013. PMID: 23912644
-
Advanced case of PKDL due to delayed treatment: A rare case report.PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0008052. doi: 10.1371/journal.pntd.0008052. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203500 Free PMC article.
-
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.J Clin Immunol. 2015 Jan;35(1):56-67. doi: 10.1007/s10875-014-0115-3. Epub 2014 Nov 25. J Clin Immunol. 2015. PMID: 25479930
-
In situ cellular immune response in non-ulcerated skin lesions due to Leishmania (L.) infantum chagasi infection.J Venom Anim Toxins Incl Trop Dis. 2021 Feb 26;27:e20200149. doi: 10.1590/1678-9199-JVATITD-2020-0149. eCollection 2021. J Venom Anim Toxins Incl Trop Dis. 2021. PMID: 33708246 Free PMC article.
-
A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome.Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17123-8. doi: 10.1073/pnas.0904955106. Epub 2009 Sep 9. Proc Natl Acad Sci U S A. 2009. PMID: 19805095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials